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ABSTRAK
Kejadian ketahanan dadah masa kini dan kesan samping beberapa dadah alopati 
telah meningkatkan penekanan ke atas penggunaan bahan tumbuhan sebagai 
sumber perubatan ke atas pelbagai penyakit termasuk leukemia. Houttuynia cordata 
Thunb (H.cordata) ialah tumbuhan setempat di utara Thailand yang dikenali sebagai 
Plucao, mempunyai pelbagai aktiviti biologi seperti anti-inflamasi, anti-kanser dan 
anti-leukemia. Tujuan kami ialah untuk menentukan komponen aktif flavonoid H. 
cordata dan menyiasat kesan ekstrak etanol H.cordata  ke atas induksi apoptosis 
pada sel leukemia limfoblastik akut manusia. Dalam kajian ini, kami mendapati 
ekstrak etanol H. cordata mempunyai jumlah flavonoid sebanyak 231.21 ± 4.19 mg 
QE/g H.cordata kering. Analisa LC-MS kuantitatif ke atas ekstrak menunjukkan ia 
mempunyai beberapa komponen flavonoid termasuk hiperin 6.35 ± 0.41, kuarsetin 
0.34 ± 0.02, isokuarsetin 1.10 ± 0.03, and rutin 0.88 ± 0.04 (%w/w). Hasil toksisiti 
menunjukkan penurunan bergantung dos pada tumbesaran sel leukemia Jurkat. 
Corak ‘blebbing’ pada sel apotosis ditemui pada sel yang dirawat ekstrak etanol 
H.cordata selama 24 dan 48 jam. Tambahan lagi, kami mendapati ekstrak tersebut 
boleh menginduksi kematian sel Jurkat melalui apoptosis pada 12 dan 24 jam. 
Kesimpulannya, hasil kajian menunjukkan bahawa ekstrak etanol H.cordata yang 
terdiri dari beberapa flavonoid mempunyai aktiviti anti-leukemik melalui induksi 
apoptosis pada sel leukemia Jurkat.
Kata kunci: leukemia limfoblastik akut, apoptosis, flavonoid, Houttuynia cordata 
Thunb, jurkat 
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for reducing the treatment side effects 
are significant and needed (Russo et al. 
2011). 
 Currently, herbal and natural 
product compounds are used as 
alternative medicine. Houttuynia 
cordata Thunb or Plucao in Thai, 
is in the Saururaceae family, and 
mostly found in Northern of Thailand 
and Asia. It has many bioactivities 
including anti-inflammation, anti-
oxidative, anti-diabetes and anti-
cancer (Yang & Jiang 2009; Cho et 
al. 2003; Wangchauy & Chanprasert 
2012).  Major active components of 
H.cordata are flavonoids, alkaloids 
and volatile oils (Xu et al. 2006; Wu 
ABSTRACT
Development of resistance to currently used drugs and side effects of several 
allopathic drugs have led to increased emphasis on plant materials uses as a source 
of medicines for a wide variety of human illnesses including leukemia. Houttuynia 
cordata Thunb (H.cordata), a Northern Thailand local plant and commonly known 
as Plucao, has various biological activities such as anti-inflammatory, anti-cancer 
and anti-leukemic activities. We aimed to determine active flavonoid components 
of H.cordata and to investigate the effect of H.cordata ethanolic extract on 
apoptotic induction on human acute lymphoblastic leukemia cells. In this study, 
we found that H.cordata ethanolic extract had total flavonoid of 231.21 ± 4.19 
mg QE/g dried H.cordata. The extract analyzed by quantitative LC-MS consists of 
several flavonoid components including hyperin 6.35 ± 0.41, quercetin 0.34 ± 0.02, 
isoquercetin 1.10 ± 0.03, and rutin 0.88 ± 0.04 (%w/w). The cytotoxicity results 
showed dose dependent decrease in growth of Jurkat leukemic cells. Blebbing 
pattern of cell apoptosis was found in cells treated with H.cordata ethanolic extract 
for 24 and 48 hrs. Moreover, we found that the extract could substantially induce 
Jurkat cell death through apoptosis at both 12 and 24 hrs. In conclusion, these 
results indicated that H.cordata ethanolic extract which is composed of several 
flavonoids, possesses anti-leukemic activity through apoptotic induction in Jurkat 
leukemia cells. 
Keywords: acute lymphoblastic leukemia, apoptosis, flavonoid, Houttuynia cordata 
thunb, jurkat
INTRODUCTION
Acute lymphoblastic leukemia (ALL), 
a clonal malignancy disease of bone 
marrow, is a life threatening neoplasm 
characterized by uncontrolled growth 
and leukemic expansion of immature 
lymphoblastic progenitor cells (Inaba et 
al. 2013). ALL is most commonly found 
in children and has poor prognosis in 
adults. The main treatment regimen of 
ALL is a combination of chemotherapy, 
but it has many side effects.  Moreover, 
there are more relapse and chemo 
resistant incidence (Winter et al. 2014). 
Therefore, screening and investigating 
anti-leukemic compounds in plants 
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et al. 2009).  Previously, several studies 
suggested that flavonoids played a 
prominent role in cancer prevention 
via ROS production, inflammatory 
regulation, cell cycle arrest and 
growth inhibitory pathways, cell signal 
transduction pathways related to cell 
proliferation and cell apoptosis (Wu et 
al. 2009; Okwu & Nnamdi 2011). In the 
present study, we aimed to determine 
active flavonoid components of H. 
cordata and to investigate the effect 
of H.cordata ethanolic extract on 
apoptotic induction on human acute 
lymphoblastic leukemia cells.
MATERIALS AND METHODS
CHEMICALS
In-vitro Toxicology assay kit, XTT Based 
(TOX2), Vincristine and Aluminium 
chloride (AlCl3) were obtained from 
Sigma-Aldrich (USA). Sodium nitrite 
(NaNO2), ethyl alcohol (EtOH), and 
sodium hydroxide (NaOH) were 
purchased from MERCK (Germany). 
RPMI medium 1640, fetal bovine 
serum (FBS), penicillin/streptomycin, 
trypan blue and apoptosis kit were 
obtained from GIBCOTM Invitrogen 
(USA).  
PLANT MATERIAL, EXTRACTION 
AND LC-MS
Whole plants of Houttuynia cordata 
Thunb were collected by our group in 
March, 2012 from Lamphun province, 
Northern Thailand. The plant was 
authenticated and a voucher specimen 
(BCU013515) was deposited at the 
Plants of Thailand Research Unit, 
Department of Botany, Faculty of 
Sciences, Chulalongkorn University, 
Bangkok, Thailand. H.cordata leaves 
were cleaned and air-dried at room 
temperature then dried for 3 days 
at 45�C. H.cordata dried leaves 
were extracted with 95% EtOH 
and lyophilized to dry as described 
previously (Wangchauy & Chanprasert 
2012). The lyophilized extract and 
flavonoid standards were dissolved in 
dimethyl sulfoxide (DMSO) and diluted 
in RPMI Medium 1640 to give final 
concentration of 5 mg/ml for H.cordata 
extract and 1 mg/ml for flavonoid 
standards, respectively. The diluted 
extract was analyzed for flavonoid 
components (%w/w) by LC-MS 
system with a Symmetry C18-column 
(Gemini C18, 250 x 4.6 mm) using a 
Dionex Ultimate 3000 in combination 
with an electrospray ionization (ESI)/
quadrupole ion trap mass spectrometer 
(Bruker Daltonik, Germany) at the 
Institute of Biotechnology and Genetic 
Engineering, Chulalongkorn University, 
Bangkok, Thailand.
TOTAL FLAVONOID CONTENT 
ASSAY
Total flavonoid content of H.cordata 
extract was measured by AlCl3 
colorimetric assay as described 
previously (Kim et al. 2003).  One ml 
of 500 μg/ml H.cordata extracts or 
standard Quercetin solution (7.8125-
1000 μg/ml) was added to 4 ml 
distilled deionized water and the 0.3 
ml of 5% NaNO2was added to the 
solution. Then, after 5 min., 0.3 ml 
of 5% AlCl3 was added. Next, at 6 
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min, 2 ml of 1M NaOH and 2.4 ml of 
distilled deionized water were added 
and the solution was thoroughly 
mixed. Afterwards, the absorbance of 
the mixture was measured at 510 nm 
versus prepared water as a blank. Total 
flavonoid of H.cordata extracts were 
expressed as mg quercetin equivalents 
(QE)/g of dried H.cordata material.
CELL LINE AND CELL CULTURE
Jurkat (TIB-152), human T cell leukemia 
cells obtained from American Type 
Culture Collection were cultured 
in RPMI-1640 supplemented with 
10% fetal bovine serum (FBS), 1% 
L-glutamine and 1% Penicillin/
Streptomycin (final concentration of 
100 units/ml penicillin and 100 mg/ml 
streptomycin). The leukemic cells were 
maintained at 37�C in humidified 5% 
CO2 environment.
CYTOTOXICITY EFFECT BY XTT-
BASED COLORIMETRIC ASSAY
H.cordata extract cytotoxic effect were 
determined by XTT assay. Jurkat cells 
were prepared at 5.0 x 105 cells/ ml and 
seeded 90 μl/well to 96-well culture 
plate. Ten μl of serial concentration of 
H.cordata extracts (5000, 2500, 1250, 
625, 312.5, 156.25 and 78.125 μg/
ml) were applied onto culture wells. 
Vincristine (10 ng/ml) and RPMI-1640 
with 0.1% dimethyl sulfoxide were 
used as positive control and negative 
control, respectively. Then, cells were 
determined for cytotoxicity with TOX2 
after 48 hrs incubation at 37�C in 
humidified 5% CO2 atmosphere. The 
absorbance was measured at 450 
nm with a reference wavelength of 
690 nm using microtiter plate reader. 
Finally, number of viable cells was 
calculated and data was showed as % 
cell viability.
CYTOTOXICITY EFFECT BY 
MICROSCOPIC ANALYSIS
Concentration of 1.0 x 105 cells/ml of 
Jurkat was prepared and seeded 900 
μl/well to 24–well culture plate. A 
hundred μl/ well of H.cordata extract 
(3000 μg/ml) was applied onto culture 
wells. Ten ng/ml Vincristine and RPMI-
1640 with 0.1% DMSO were used 
as positive and negative controls, 
respectively. After incubation for 24 
and 48 hrs at 37�C in humidified 5% 
CO2 environment, cells were assayed 
with an inverted light microscope.
APOPTOSIS ASSAY BY FLOW 
CYTOMETRY
Jurkat leukemic cells were prepared at 
a final concentration of 1.0 x 106 cells/
well. Cells were cultured in 6-well 
culture plates and treated with fresh 
RPMI medium containing H.cordata 
extract at final concentration of 
300 μg/ml. Ten ng/ml Vincristine 
and RPMI medium 1640 with 0.1% 
DMSO were used as positive and 
negative controls, respectively.
Cultured cells were incubated for 12 
and 24 hrs at 37�C in a humidified 5% 
CO2 environment. Jurkat cells were 
harvested and incubated with Alexa 
Flour 488 annexin V and propidium 
iodide (PI) in the dark. Apoptotic cells 
were analyzed by FACS Calibur flow 
cytometer (Becton Dickinson, USA).
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STATISTICAL ANALYSIS
Data were expressed as mean ± SEM. 
Differences were evaluated statistically 
using one-way analysis of variance 
(ANOVA) test. p-value < 0.05 was 
considered statistically significant.
RESULTS
H.CORDATA ETHANOLIC 
EXTRACT’S TOTAL FLAVONOID 
DETERMINATION
Total flavonoids content of H.cordata 
ethanolic extract was 231.21 ± 4.19 mg 
QE/g dried H.cordata.
H.CORDATA EXTRACT 
FLAVONOID COMPONENT 
ANALYSIS BY LC-MS 
H.cordata ethanolic extract was 
analyzed by reverse phase-high 
performance liquid chromatography 
and mass spectrometry. We found that 
flavonoid components of H.cordata 
crude extract were quercetin, 
isoquercetin, hyperin and rutin as 
shown in Table 1.
CYTOTOXICITY OF H.CORDATA 
ETHANOLIC EXTRACT
Jurkat cells were treated with H.cordata 
extract at various concentrations. The 
H.cordata extract cytotoxicity was 
assessed as cell viability using the XTT 
assay as shown data in Figure 1. The 
concentration required for inhibiting 
growth by 50% (IC50) for 48 hrs on 
Jurkat cells was 469.01 ± 6.32 μg/ml 
of H.cordata extract. The data showed 
that H.cordata extract can inhibit 
leukemic cell growth. 
CYTOTOXICITY EFFECTS OF 
H.CORDATA EXTRACT BY 
MICROSCOPIC ANALYSIS
After incubation for 24 and 48 hrs of 
Jurkat cells with 300 μg/ml H.cordata 
extract, microscopic analysis showed 
Table 1: Flavonoid components of Houttuynia cordata Thunb ethanolic extract analyzed 
by LC-MS.
Flavonoid compositions %w/w
Quercetin 0.34 ± 0.02
Isoquercetin 1.10 ± 0.03
Hyperin 6.35 ± 0.41
Rutin 0.88 ± 0.04
Figure 1: Effect of H. cordata ethanolic extract 
on Jurkat cell viability. Treated Jurkat with 
various concentrations of H. cordata extract. 
Vincristine (10 ng/ml) and RPMI-1640 with 
0.1% DMSO were used as positive control and 
negative control, respectively. Data are shown 
as mean ± S.D. (n=3).
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the blebbing pattern of apoptotic cell 
as shown in Figure 2 suggesting that 
H.cordata extract might involve the 
apoptotic process of leukemic cells.  
Interestingly, the number of Jurkat cells 
after treatment with H.cordata extract 
for 24 and 48 hrs were significantly 
lower than negative control, which 
means that H.cordata extract can 
inhibit leukemic cell growth that is 
consistent with the cytotoxicity test 
(XTT assay) as described above.
EFFECT OF H.CORDATA EXTRACT 
ON APOPTOTIC INDUCTION BY 
FLOW CYTOMETRY ANALYSIS
After incubation for 12 and 24 hrs of 
Jurkat cells with H.cordata extract 
(300 μg/ml), cells were stained with 
AnxV and PI. The apoptotic cells 
were analyzed by flow cytometer. The 
frequency of early apoptosis (Anx V-/
PI+) and late apoptosis (Anx V+/PI+) 
cells are indicated by numbers in the 
corresponding quadrants. As shown in 
Figure 3, the data demonstrated that 
the ethanolic extract of H.cordata can 
induce a significant increment of Jurkat 
cell death through apoptosis at both 
12 and 24 hrs compared with negative 
control.
DISCUSSION
In general, most treatment plans for 
acute lymphoblastic leukemia have 
three steps. These are induction, 
Figure 2: Cytotoxic effect of H.cordataextract on Jurkat cells by microscopic analysis.Microscopic 
analysis showed membrane blebbing (arrow) of apoptotic cell(A) Negative control-24 h, (B) Negative 
control-48 h, (C) Positive control-24 h, (D) Positive control-48 h, (E) H.cordataextract (300 µg/ml)-24 
h, (F) H.cordataextract (300 µg/ml)-48 h.
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consolidation, and maintenance. For 
the purpose of improving the survival 
rate and preventing remission and 
relapse of leukemia, leukemic treatment 
have several methods including 
chemotherapy, radiotherapy and bone 
marrow or stem cell transplantation. 
Nevertheless, many side-effects such 
as headache, vomiting, nausea and 
weight-loss occurred after treatment. As 
a result, herbal therapy is an alternative 
method for leukemia treatment which 
diminishes side effects. Currently, 
there are several leukemic treatments 
from plant-derived compounds 
used in clinical including vincristine, 
vinblastine, camptothecin and 
paclitaxel (Riccardi et al. 1995; Myrick 
et al. 1999; Goossens et al. 2000; 
Liu et al. 2007). Our previous studies 
demonstrated that H.cordata Thunb 
extract can inhibit growth and induce 
apoptosis in human leukemic cells 
(Pawinwongchai & Chanprasert 2011; 
Wangchauy & Chanprasert 2012).
 In present study, we found that 
A) Negative control (0.1% DMSO)
B) Positve control (vincristine 10 ng/ml)
C) H. cordata extract (300 μg/ml)
Figure 3: H. cordata extract induces apoptosis in human acute lymphoblastic leukemia cells. Flow 
cytometry analysis of Jurkat cells treated with DMSO (A), vincristine (B) and H. cordata extract (C) 
for 12 and 24 hours. Representative figures showing population of viable (Q3), early apoptotic (Q4), 
late apoptotic (Q2) and necrotic (Q1) cells.
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quercetin, isoquercetin, hyperin 
and rutin are the major flavonoid 
components in H.cordata Thunb 
extract from Northern Thailand.  
These results are consistent with the 
findings of previous study in China 
(Wu et al. 2009). However, flavonoid 
components from different sites show 
the different proportion of flavonoids 
according to the geographical origin.
 In  the present study, we investigated 
the  effect of H.cordata extract in 
Jurkat leukemia cells which were the 
representative of ALL. We found that 
the extract can inhibit cell proliferation 
in dose dependent manner. By 
microscopic analysis, we found 
that the number of Jurkat cells after 
treatment with H.cordata extract and 
positive control for 24 hrs and 48 hrs 
were significantly lower than negative 
control, which means H.cordata extract 
can inhibit leukemic cell growth that 
consistent with the cytotoxicity test 
(XTT assay).  Interestingly, membrane 
blebbing is the morphological feature 
of apoptosis which is found in Jurkat 
treated with H.cordata extract for both 
24 hrs and 48 hrs that is similar to 
the cells treated with vincristine. Late 
apoptotic cell exhibited cytoplasmic 
blebbing and irregularity in shape 
apoptotic bodies. In the same way, 
Pupalialappacea, containing flavonoid 
rutin as the main component, caused 
the morphological changes in K562 
cell by cell shrinkage and membrane 
blebbing when treated with the extract 
for 24 h (Ravi et al. 2012).
 In order to confirm the above result, 
we investigated the apoptotic effect 
of H.cordata extract in Jurkat cells. 
Apoptotic death cells were analyzed in 
early apoptosis and late apoptosis by 
flow cytometry analysis. Our data once 
again confirmed the effect of H.cordata 
extract on induction of apoptosis in 
Jurkat leukemic cells, consistent with 
previous study of Chang et al. (2001) 
which demonstrated that H.cordata 
extract could inhibit 5 leukemic cells 
including K562, U937, L1210, Raji and 
P3HR1cells at IC50 between 478 to 662 
μg/ml but was well tolerated by healthy 
human cell at IC50 greater than 1,000 
μg/ml. Nevertheless, the molecular 
mechanisms of cell death induction by 
H.cordata extract remained unclear. 
The possible molecular signaling 
pathway of cell death in response to 
H.cordata may be via intrinsic pathway.  
However, intrinsic and extrinsic 
pathways or autophagy-associated cell 
death pathway still need further studies 
to identify in deep.  
CONCLUSION
In summary, our study demonstrated 
that H.cordata ethanolic extract 
composed of active flavonoids and 
can inhibit cell proliferation and 
induce apoptosis in Jurkat leukemia 
cells. H.cordata may be useful in the 
combination of leukemia treatment in 
the future. However, besides the use 
of cell model, animal experiments 
and human critical trials should be 
employed to explore the possible 
applications of H.cordata and its 
flavonoids for the treatment.
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